EU waiver allows U.S. API imports without additional certificates

06/25/2013 | Pharmaceutical Processing

The U.S. FDA said it has secured a waiver from the EU that will allow American companies to export active pharmaceutical ingredients to Europe without first submitting documentation of good manufacturing practices. Without the waiver, documentation of compliance with European standards by U.S. companies would have been required starting in July.

View Full Article in:

Pharmaceutical Processing

Published in Brief: